PTGX icon

Protagonist Therapeutics

38 hedge funds and large institutions have $175M invested in Protagonist Therapeutics in 2016 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 21 increasing their positions, 6 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
38
Holders Change
+4
Holders Change %
+11.76%
% of All Funds
0.95%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
8
Increased
21
Reduced
6
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Wells Fargo
26
Wells Fargo
California
$115K +$115K +5,219 New
NFA
27
Nationwide Fund Advisors
Ohio
$108K +$62K +2,833 +135%
Deutsche Bank
28
Deutsche Bank
Germany
$94K +$66.5K +3,073 +242%
BA
29
BlackRock Advisors
Delaware
$61K +$3.38K +153 +6%
SO
30
STRS Ohio
Ohio
$52K
UBS Group
31
UBS Group
Switzerland
$32K +$8.29K +374 +35%
Legal & General Group
32
Legal & General Group
United Kingdom
$30K +$30K +1,343 New
Bank of America
33
Bank of America
North Carolina
$23K +$23K +1,043 New
Creative Planning
34
Creative Planning
Kansas
$15K +$11.1K +500 +282%
Royal Bank of Canada
35
Royal Bank of Canada
Ontario, Canada
$8K +$3.52K +157 +79%
BNP Paribas Financial Markets
36
BNP Paribas Financial Markets
France
$7.98K +$2.02K +92 +34%
BlackRock
37
BlackRock
New York
$6K +$6K +262 New
Barclays
38
Barclays
United Kingdom
$5K +$5K +218 New
BI
39
BVF Inc
California
-$7.92M -375,000 Closed
CS
40
Credit Suisse
Switzerland
-$358K -16,924 Closed
Goldman Sachs
41
Goldman Sachs
New York
-$282K -13,340 Closed
Jane Street
42
Jane Street
New York
-$232K -10,964 Closed